Menstrual Related Trials
PEtAL
Phenotyping the Endometrium in Adenomyosis and Leiomyoma
WHY?
To understand the changes that are occurring in the womb at a cellular and molecular level, when women have heavy periods which are caused by fibroids (excess growth of the muscle layer of the womb) or adenomyosis (cells from the lining of the womb found in the muscle layer of the womb).
WHO?
Women with regular menstrual cycles who are not taking hormonal medication, with fibroids, adenomyosis or both or women with no cause found for their heavy periods
WHERE?
NHS Lothian
For further information contact:
Research Office: 0131 242 2483 (voicemail available)
A randomised controlled trial and exploration of mechanism of action study for Ulipristal acetate (UPA) versus conventional management of heavy menstrual bleeding (HMB).
WHY?
The study aims to determine if Ulipristal acetate (UPA) is more effective at reducing heavy menstrual bleeding than LNG-IUS (hormone intrauterine system) after 12 months of treatment.
WHO?
Women (>18yrs) with heavy menstrual bleeding.
WHERE?
Multi-centre trial (sites include: Edinburgh, Glasgow, Aberdeen, Birmingham, Liverpool)
For further information contact:
Research Office: 0131 242 2483 (voicemail available)